ClinicalTrials.gov
public full text
Public Domain
Intracavernous Injection of Botox 100 U for Treatment of PDE5Is Inconvenient Patients With ED
There is a new emerging concept that Botulinum Toxin Type A may have a potential role in treatment of erectile dysfunction with a longer duration of action. So, the investigators opted to perform this study to compare ICI of Botulinum Toxin Type A versus Trimix for treatment of ED.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intra-muscular Botulinum Toxin A in Chronic Athletic Pubalgia#842382
- Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter Muscles#901154
- Phase IV Study On Muscle Activity Of Two Commercial Preparations Of Botulinum#1096888
- Injection of Botulinum Toxin for Thumb Carpometacarpal Arthritis#905398
- Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia#966775
Record · ID 1114605
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive